| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
group | 0.110 | None | 1.000 | 3 | 1 | 2002 | 2014 | ||||||||
|
mediator complex subunit 12 | 0.476 | 0.769 | 1.00 |
|
group | 0.430 | None | 1.000 | 1 | 1 | 2014 | 2016 | ||||||||
|
ALK receptor tyrosine kinase | 0.396 | 0.846 | 3.2E-06 |
|
group | 0.400 | None | 1.000 | 1 | 1 | 2016 | 2018 | ||||||||
|
splicing factor 3b subunit 1 | 0.511 | 0.731 | 1.00 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
fibroblast growth factor receptor 4 | 0.490 | 0.769 | 7.2E-13 |
|
group | 0.140 | None | 1.000 | 1 | 1 | 2003 | 2010 | ||||||||
|
Rho associated coiled-coil containing protein kinase 1 | 0.513 | 0.731 | 1.00 |
|
group | 0.120 | None | 1.000 | 1 | 1 | 2005 | 2010 | ||||||||
|
BRCA1 associated RING domain 1 | 0.597 | 0.538 | 1.4E-24 |
|
group | 0.450 | None | 1.000 | 0 | 1 | 2004 | 2008 | ||||||||
|
BRCA1 interacting protein C-terminal helicase 1 | 0.507 | 0.731 | 6.2E-17 |
|
group | 0.450 | None | 1.000 | 0 | 1 | 2003 | 2008 | ||||||||
|
Bruton tyrosine kinase | 0.464 | 0.808 | 1.00 |
|
group | 0.100 | None | 1.000 | 1 | 2 | 2014 | 2014 | ||||||||
|
exportin 1 | 0.504 | 0.692 | 1.00 |
|
group | 0.120 | None | 1.000 | 1 | 2 | 2016 | 2019 | ||||||||
|
protein phosphatase 2 scaffold subunit Aalpha | 0.588 | 0.577 | 0.98 |
|
group | 0.100 | None | 1.000 | 1 | 2 | 2016 | 2016 | ||||||||
|
DNA polymerase epsilon, catalytic subunit | 0.526 | 0.731 | 8.0E-27 |
|
group | 0.110 | None | 1.000 | 1 | 2 | 2009 | 2016 | ||||||||
|
splicing factor 3b subunit 2 | 0.780 | 0.308 | 1.00 |
|
group | 0.100 | None | 1.000 | 1 | 2 | 2016 | 2016 | ||||||||
|
SMAD family member 4 | 0.401 | 0.808 | 1.00 |
|
group | 0.150 | None | 1.000 | 1 | 2 | 1997 | 2016 | ||||||||
|
isocitrate dehydrogenase (NADP(+)) 1 | 0.424 | 0.808 | 2.6E-12 |
|
group | 0.100 | None | 1.000 | 1 | 2 | 2016 | 2016 | ||||||||
|
GNAS complex locus | 0.420 | 0.885 | 0.68 |
|
group | 0.100 | None | 1.000 | 1 | 2 | 2016 | 2016 | ||||||||
|
chromosome 11 open reading frame 65 | 0.670 | 0.462 | 2.0E-14 |
|
group | 0.100 | None | 0 | 2 | |||||||||||
|
ATM serine/threonine kinase | 0.374 | 0.885 | 5.6E-47 |
|
group | 0.500 | None | 0.974 | 0 | 2 | 1996 | 2018 | ||||||||
|
HECT and RLD domain containing E3 ubiquitin protein ligase 2 | 0.568 | 0.692 | 1.00 |
|
group | 0.100 | None | 1.000 | 2 | 3 | 2006 | 2013 | ||||||||
|
erb-b2 receptor tyrosine kinase 3 | 0.448 | 0.808 | 1.7E-15 |
|
group | 0.500 | None | 1.000 | 1 | 3 | 1999 | 2018 | ||||||||
|
ras homolog family member A | 0.502 | 0.808 | 0.60 |
|
group | 0.140 | None | 1.000 | 1 | 3 | 2004 | 2016 | ||||||||
|
F-box and WD repeat domain containing 7 | 0.465 | 0.808 | 1.00 |
|
group | 0.420 | None | 0.667 | 1 | 4 | 2008 | 2016 | ||||||||
|
fibroblast growth factor receptor 2 | 0.380 | 0.808 | 1.00 |
|
group | 0.500 | None | 0.950 | 1 | 4 | 1991 | 2016 | ||||||||
|
checkpoint kinase 2 | 0.460 | 0.808 | 1.2E-24 |
|
group | 0.500 | None | 0.964 | 11 | 5 | 2002 | 2017 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
group | 0.500 | None | 0.978 | 3 | 5 | 1988 | 2020 |